Mechanisms and Therapeutic Options of Hypersomnia in Myotonic Dystrophy
强直性肌营养不良的嗜睡机制和治疗选择
基本信息
- 批准号:9977456
- 负责人:
- 金额:$ 43.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectAffinityAlternative SplicingAntibioticsAntisense OligonucleotidesBindingBiological MarkersBrainCUG repeatCell modelCellsCharacteristicsCongenital neurologic anomaliesCytosineDevelopmentDiseaseDoseErythromycinEventExcessive Daytime SleepinessFDA approvedFibroblastsGenesGenetic TranscriptionGuanineHumanHypersomniasImpairmentInfantKnockout MiceLifeModelingMonitorMusMuscleMutationMyotoniaMyotonic DystrophyMyotonic dystrophy type 1Nervous System PhysiologyNeuraxisNeurologic SymptomsOral AdministrationOrganPathologicPatientsPermeabilityPhenotypeProteinsREM SleepRNARNA SplicingReportingScientistSkeletal MuscleSleepSpliced GenesSymptomsTestingTherapeuticThymineTissuesToxic effectTranscriptTransgenic OrganismsTrinucleotide Repeatsbehavioral phenotypingblindexperimental studyhuman datamedication safetymouse modelmutantresponsesleep abnormalitiessleep patternsmall moleculetransgene expression
项目摘要
Excessive daytime sleepiness (EDS) and associated alterations in rapid eye movement (REM)
sleep patterns are among the most characteristic non-muscular features of myotonic dystrophy (DM).
Today there are no means to ameliorate the neurological symptoms of DM1. Major pathological
changes in the DM brain are attributable to toxic RNA expression, muscleblind-like protein (Mbnl)
sequestration by C(C)UG expansion RNAs, and dysregulation of specific alternative splicing events
required for normal adult central nervous system (CNS) function. We recently demonstrated that REM
sleep propensity is increased specifically in DM1, using mouse models of DM1 (i.e., Mbnl2 KO mice).
Since infant type gene splicing remains in many genes of patients in adult DM, we believe that REM
sleep abnormalities in DM may be a remnant of infant type sleep. Available human data suggest that
abnormally increased REM sleep propensity may cause EDS. If our hypothesis is correct, we may be
able to treat sleep abnormalities of DM patients by reducing RNA toxicity.
Nakamori et al. recently reported that erythromycin, a FDA approved antibiotic, showed high affinity
to CUG expansions and a capacity to inhibit its binding to MBNLs. Erythromycin decreased foci
formation and rescued missplicing in DM1 cell. Furthermore, oral administrations of erythromycin at a
dose commonly used in humans showed splicing reversal and improvement of myotonia with no toxicity
in the DM1 model mice. Since erythromycin penetrates into the CNS, we expect that it rescues
missplicing in genes in the CNS and normalize the sleep abnormalities in DM1. We will therefore
propose the following experiments to test our hypothesis and seek new treatment options for the sleep
and CNS abnormalities of DM1. (1) Evaluate sleep and behavioral phenotypes in the DMSXL
transgenic (with human DMPK mutation) and littermate WT mice in adulthood and during early
developmental periods, (2) Evaluate the RNA toxicity-reversing effect of erythromycin in the brain of the
DMSXL mice and (3) Evaluate if erythromycin normalizes sleep and CSN abnormalities in the DMSXL
mice.
白天过度嗜睡(EDS)和快速眼动(REM)的相关改变
睡眠模式是强直性肌营养不良(DM)的最典型的非肌肉特征之一。
今天,没有办法改善DM1的神经症状。主要病理
DM脑的变化可归因于毒性RNA表达、肌盲样蛋白(Mbnl)
C(C)UG扩增RNA的隔离和特异性选择性剪接事件的失调
正常成人中枢神经系统(CNS)功能所需的。我们最近证明了快速眼动
使用DM1的小鼠模型(即,Mbnl2 KO小鼠)。
由于婴儿型基因剪接在成人DM患者的许多基因中仍然存在,我们认为REM
糖尿病睡眠异常可能是婴儿型睡眠的残留。现有的人类数据表明,
REM睡眠倾向的异常增加可能导致EDS。如果我们的假设是正确的,
能够通过降低RNA毒性来治疗DM患者的睡眠异常。
Nakamori等最近报道,红霉素,一种FDA批准的抗生素,
和抑制其与MBNL结合的能力。红霉素减少病灶
形成和挽救的错剪接。此外,口服给药红霉素,
人类常用剂量显示剪接逆转和肌强直改善,无毒性
在DM1模型小鼠中。由于红霉素渗透到中枢神经系统,我们希望它能挽救
在中枢神经系统基因的错误剪接和正常化的睡眠异常DM1。因此我们将
我提出以下实验来验证我们的假设,并寻求新的治疗方案,为睡眠
和DM1的CNS异常。(1)在DMSXL中评估睡眠和行为表型
在成年期和早期阶段,
(2)评价红霉素在小鼠脑中的RNA毒性逆转作用。
(3)评价红霉素是否使DMSXL小鼠的睡眠和CSN异常正常化
小鼠
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SEIJI NISHINO其他文献
SEIJI NISHINO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SEIJI NISHINO', 18)}}的其他基金
Brain Mast Cells in Sleep and Behavioral Regulation
睡眠和行为调节中的脑肥大细胞
- 批准号:
9000177 - 财政年份:2015
- 资助金额:
$ 43.86万 - 项目类别:
Diagnostic Values of Plasma Hypocretin Measures for Sleep Disorders
血浆下丘脑分泌素测量对睡眠障碍的诊断价值
- 批准号:
7564059 - 财政年份:2008
- 资助金额:
$ 43.86万 - 项目类别:
Diagnostic Values of Plasma Hypocretin Measures for Sleep Disorders
血浆下丘脑分泌素测量对睡眠障碍的诊断价值
- 批准号:
7469299 - 财政年份:2008
- 资助金额:
$ 43.86万 - 项目类别:
Role of Histamine in Narcolepsy/EDS Disorders
组胺在发作性睡病/EDS 疾病中的作用
- 批准号:
7186303 - 财政年份:2007
- 资助金额:
$ 43.86万 - 项目类别:
Role of hypocretin/histamine in Narcolepsy/EDS disorders
下丘脑分泌素/组胺在发作性睡病/EDS 疾病中的作用
- 批准号:
7149390 - 财政年份:2006
- 资助金额:
$ 43.86万 - 项目类别:
Role of hypocretin/histamine in Narcolepsy/EDS disorders
下丘脑分泌素/组胺在发作性睡病/EDS 疾病中的作用
- 批准号:
7454331 - 财政年份:2006
- 资助金额:
$ 43.86万 - 项目类别:
Role of hypocretin/histamine in Narcolepsy/EDS disorders
下丘脑分泌素/组胺在发作性睡病/EDS 疾病中的作用
- 批准号:
7643417 - 财政年份:2006
- 资助金额:
$ 43.86万 - 项目类别:
Role of hypocretin/histamine in Narcolepsy/EDS disorders
下丘脑分泌素/组胺在发作性睡病/EDS 疾病中的作用
- 批准号:
7261383 - 财政年份:2006
- 资助金额:
$ 43.86万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 43.86万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 43.86万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 43.86万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 43.86万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 43.86万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 43.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 43.86万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 43.86万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 43.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 43.86万 - 项目类别:
Studentship














{{item.name}}会员




